eFFECTOR Therapeutics (EFTR): Total Nilai Bisnis

Tandha merek eFFECTOR Therapeutics (EFTR)

Despite the absolute independence of biotech demand from macroeconomic cycles, eFFECTOR Therapeutics (EFTR) ceased operations and liquidated its assets following failed drug trials in mid-2024. This chart on the GURU.Markets platform shows the enterprise value at . Currently, business development is being hindered by geopolitical risks, which are blocking international logistics and the conduct of global clinical trials.

EFTR (eEFFECTOR Therapeutics, Inc.) riwayat Nilai Total Perusahaan saka 04.07.2022 nganti 28.10.2026
Produk sing diprodhuksi eEFFECTOR Therapeutics, Inc.

For a conservative investor, the aggregate valuation of eFFECTOR Therapeutics (EFTR) assets, calculated as the sum of market capitalization and net debt, serves as an objective measure of the cost of a full business acquisition. In the case of eFFECTOR Therapeutics (EFTR), this indicator reflects the real cost of ownership for a unique scientific protein translation platform, which retains leading biochemists through intellectual capital and stock option programs, thereby determining the issuer's long-term investment attractiveness.